DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Blood Cancer Awareness Month: Key Trends in the Hematology Oncology Market

Blood Cancer Awareness Month: Key Trends in the Hematology Oncology Market

Dr. Andrew Merron, Executive Director, DRG Oncology

For Blood Cancer Awareness Month, Dr. Andrew Merron discusses major themes in hematology oncology and his predictions:

  • The opportunity for new therapies in hematological cancer
  • Role of CAR T-cells in hematological malignancies
  • 4 key takeaways for pharma

 

Visit DRGOncology.com for more insights from Andrew and other oncology experts.